本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cyclo Therapeutics Inc

0.0320
0.0000
成交量:- -
成交额:- -
市值:- -
市盈率:-0.03
高:0.0320
开:0.0320
低:0.0320
收:0.0320
52周最高:0.0320
52周最低:0.0320
股本:- -
流通股本:- -
量比:3.25
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.9232
净资产收益率:-22663.91%
总资产收益率:-284.27%
市净率:0.00
市盈率(LYR):- -

数据加载中...

2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/06/25

重要事件披露

8-K - Current report
2021/05/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/22

重要事件披露

8-K - Current report
2020/12/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/11

重要事件披露

8-K - Current report
2020/12/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/04

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/17

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/16

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/10/23

重要事件披露

8-K - Current report
2020/09/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933